BioCentury
ARTICLE | Financial News

MyoKardia raises $46M in series B

May 1, 2015 1:18 AM UTC

Cardiovascular company MyoKardia Inc. (South San Francisco, Calif.) raised $46 million on Thursday in a series B financing from Casdin Capital; Cormorant Asset Management; Perceptive Life Sciences; an affiliate of Cowen Group; BridgeBio LLC; Sanofi (Euronext:SAN; NYSE:SNY); and an undisclosed public investment fund.

Last month, MyoKardia started a Phase I trial of lead compound MYK-461, an allosteric modulator of cardiac myosin, to treat hypertrophic cardiomyopathy (HCM). ...